ALA 11.1% 15.0¢ arovella therapeutics limited

See below Review of Mass Drug Administration for Malaria and Its...

  1. 408 Posts.
    lightbulb Created with Sketch. 14
    See below
    Review of Mass Drug Administration for Malaria and Its Operational Challenges.

    Newby G1, Hwang J2, Koita K1, Chen I1, Greenwood B1, von Seidlein L1, Shanks GD1, Slutsker L1, Kachur SP1, Wegbreit J1, Ippolito MM1, Poirot E1, Gosling R1.
    Author information

    • 1The Malaria Elimination Initiative, Global Health Group, University of California, San Francisco, California; Malaria Branch and Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia; London School of Hygiene and Tropical Medicine, London, United Kingdom; Mahidol-Oxford Tropical Medicine Research Unit, Bangkok, Thailand; Australian Army Malaria Institute, Enoggera, Australia; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland.
    • 2The Malaria Elimination Initiative, Global Health Group, University of California, San Francisco, California; Malaria Branch and Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia; London School of Hygiene and Tropical Medicine, London, United Kingdom; Mahidol-Oxford Tropical Medicine Research Unit, Bangkok, Thailand; Australian Army Malaria Institute, Enoggera, Australia; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland [email protected].
    Abstract

    Mass drug administration (MDA) was a component of many malaria programs during the eradication era, but later was seldomly deployed due to concerns regarding efficacy and feasibility and fear of accelerating drug resistance. Recently, however, there has been renewed interest in the role of MDA as an elimination tool. Following a 2013 Cochrane Review that focused on the quantitative effects of malaria MDA, we have conducted a systematic, qualitative review of published, unpublished, and gray literature documenting past MDA experiences. We have also consulted with field experts, using their historical experience to provide an informed, contextual perspective on the role of MDA in malaria elimination. Substantial knowledge gaps remain and more research is necessary, particularly on optimal target population size, methods to improve coverage, and primaquine safety. Despite these gaps, MDA has been used successfully to control and eliminate Plasmodium falciparum and P. vivax malaria in the past, and should be considered as part of a comprehensive malaria elimination strategy in specific settings.
    © The American Society of Tropical Medicine and Hygiene.

    Evidence Review Groups (ERGs)

    Evidence Review Groups (ERGs) are expert groups convened for a limited time period to review a specific area of work, and to provide evidence-based information and options for recommendations. So far, the following ERGs have met under the umbrella of the MPAC.
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
(20min delay)
Last
15.0¢
Change
0.015(11.1%)
Mkt cap ! $157.7M
Open High Low Value Volume
14.0¢ 15.0¢ 14.0¢ $106.6K 736.6K

Buyers (Bids)

No. Vol. Price($)
10 487932 14.0¢
 

Sellers (Offers)

Price($) Vol. No.
14.5¢ 50000 1
View Market Depth
Last trade - 15.36pm 16/08/2024 (20 minute delay) ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.